PET Response Assessment
Progressive Metabolic Disease: — What This PET Result Means
If your PET report says progressive metabolic disease, it means the scan is showing more cancer activity than before. This page explains the term, what happens next, and what to ask your oncologist.
Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026
- A classification, not a verdict — PMD is a standardised scoring category. It is not a clinical decision about your treatment.
- Measured against your last scan — The result only has meaning compared to a prior baseline — the two scans together tell the story.
- A review follows — Your oncologist will look at the result alongside your symptoms and other markers before recommending a change.
- Questions are expected — Asking exactly what changed and what the options are is the right next step.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Progressive metabolic disease (PMD) is a PERCIST classification. It means your PET scan shows that cancer activity has increased significantly since your last scan, or new active areas have appeared. A PMD result starts a clinical review — it does not automatically decide your next treatment. That decision depends on your full clinical picture.
What do the terms in your PET report mean?
- Progressive Metabolic Disease (PMD)
- A PERCIST classification meaning that cancer activity on the PET scan has increased significantly compared to your previous scan, or new metabolically active areas have appeared. It is the PET-based equivalent of progressive disease on a CT scan.
- PERCIST
- PET Response Criteria in Solid Tumors. The framework used to classify treatment response on PET scans. It has four categories: complete metabolic response, partial metabolic response, stable metabolic disease, and progressive metabolic disease.
- SUVmax
- Standardised Uptake Value — the number in your PET report that measures how actively an area is consuming radioactive glucose. PERCIST compares this value between scans to determine which response category applies.
- Baseline scan
- The PET scan taken before or at the start of treatment. All later scans are measured against it. A PMD result only has meaning when a valid baseline exists to compare against.
- Metabolic activity
- How actively cells are using energy. Cancer cells typically consume far more glucose than normal cells, which is why they appear bright on PET. A significant rise in metabolic activity between scans suggests the cancer is more active than before.
What does your oncologist do after a PMD result?
A PMD result starts a clinical review, not an automatic change to your treatment. Your oncologist will look at your symptoms, blood markers, how long you have been on your current treatment, and how the result compares to all previous scans.
In some situations they may recommend a biopsy before changing treatment — particularly where there is a possibility that what looks like progression is an unusual immune reaction, sometimes called pseudo-progression.
The outcome of that review is a treatment discussion. Your oncologist will explain what the options are and what each one is intended to achieve. That conversation is where treatment decisions belong, not in the report itself.
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What to do before you see your oncologist about this result
- Note any new or worsening symptomsWrite down when they started and whether they are getting worse. Even symptoms that seem unrelated may be relevant.
- Ask when the review appointment will happenA PMD result should be discussed face to face within days, not at a routine appointment weeks away. If you do not have one booked, call the clinic.
- Bring someone with youIt is very hard to take in and retain information in this kind of appointment. A second person helps you remember what was said.
- Ask what will happen to your current treatmentYou need a clear answer about whether it continues, pauses, or stops — and what comes next if it stops.
- Ask whether further investigation is plannedSpecifically, whether a biopsy or additional imaging will be done before any new treatment decision is made.
- Ask about clinical trialsTrials designed for cancer that has progressed on prior treatment may be open at CION or a partner centre.
Questions this result raises
Does PMD mean the current treatment has completely failed?
PMD means cancer activity has increased beyond the PERCIST threshold on this scan. Whether that means the treatment has stopped working entirely depends on the broader picture — your symptoms, your other markers, and the pattern across all your scans. Your oncologist will look at all of that before reaching a conclusion. In some situations treatment is modified rather than stopped; in others it changes. That determination is not made from the scan result alone.
Could the result be affected by a technical factor rather than disease change?
A single PET measurement can be influenced by factors unrelated to disease change — how well you fasted before the scan, your blood glucose level at the time, differences in scanner calibration between centres, and timing relative to your last treatment. These are reasons your oncologist considers context alongside the number, not reasons to dismiss the result. If there is genuine uncertainty, a repeat scan or biopsy may be recommended before a major treatment decision is made.
Is PMD the same as progressive disease on a CT scan?
They measure different things. CT progressive disease means a tumour has grown in physical size. PMD means metabolic activity — glucose consumption — has increased significantly, or new metabolically active sites have appeared. A tumour can show PMD before it is large enough to meet CT progression criteria, and a tumour can appear unchanged in size on CT while its metabolic activity drops. Your oncologist uses both types of information together rather than relying on either alone.
What is pseudo-progression, and could this result be that?
Pseudo-progression is an apparent increase in tumour activity on imaging caused by the immune response to treatment rather than actual cancer growth. It is more commonly associated with immunotherapy. If your oncologist suspects it, they may recommend watching and rescanning before changing treatment, or a biopsy to clarify. It is not common, but raising the question with your oncologist is reasonable if you are on immunotherapy or another treatment where it has been described.
Does PMD mean the cancer has spread to new parts of the body?
Not necessarily. New metabolically active areas on a PET scan can mean spread to new locations, but they can also mean that existing small areas have become more active and are now detectable at the scan's threshold. Your oncologist and the nuclear medicine specialist will look at exactly where any new findings are and what they look like. Ask them to explain what specifically has changed and where — reading the report alone, without that guidance, is rarely helpful.
Did you know?
PET scans measure metabolic activity, not anatomy. This means they can detect changes in how cancer cells are behaving before those changes are large enough to measure on a CT scan — which is why a PERCIST result and a RECIST result on the same patient can point in different directions.
EANM and SNMMI guidance is that PET response assessment is always interpreted alongside the clinical picture, not as a standalone number.
Source: EANM/SNMMI Procedure Guidelines for Tumour PET Imaging
A whole-body PET-CT at CION is Rs 10,499 — among the lowest published prices in Hyderabad — with a free Rs 950 oncologist consultation to talk through your report. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
What does progressive metabolic disease mean in plain language?
It means that when your PET scan was compared to the previous one, the cancer activity was significantly higher — either existing areas had increased beyond the PERCIST threshold, or new active areas had appeared. The 'metabolic' part refers to how PET measures cancer: not by size, but by how actively cells are using energy. Your oncologist will explain exactly which areas changed and by how much.
Is one PMD result enough to change treatment?
Often the clinical review that follows will lead to a change, but it is not automatic. Your oncologist will look at the scan result alongside your symptoms and other markers. If there is any uncertainty about whether the result reflects true progression — or a technical factor or pseudo-progression — they may recommend a repeat scan or biopsy before committing to a change. Ask your oncologist what else they need to consider before a decision is made.
What treatment options might be considered after PMD?
The options depend on your cancer type, which treatments you have already had, your current fitness, and what is available. A different chemotherapy regimen, a targeted therapy if a suitable marker has been identified, or immunotherapy may be discussed. Clinical trials designed for cancer that has progressed on prior treatment are also worth asking about. Your oncologist will explain what each option is intended to achieve for your specific situation — and what to expect if you choose not to pursue further active treatment.
How quickly does a PMD result need to be discussed?
Your oncologist should contact you to discuss the result and the next steps, and that conversation should happen within days of the report being available — not at a routine appointment weeks away. If you have a PMD result and have not heard from your team, call the clinic and ask when you will be seen. Waiting several weeks before discussing a progression result is not appropriate.
Will I feel differently because of a PMD result?
The scan result itself does not change how you feel — it is a measurement, not a treatment. Whether you notice new or worsening symptoms depends on where the progression is and how active it has become. Some people have a PMD result before noticing any change; others have already been aware that something is different. Tell your oncologist about any new symptoms, particularly those that started or worsened around the time of the scan.
Can I get a second opinion on this result?
Yes, and it is entirely reasonable to ask for one. A second opinion can cover the scan interpretation, the treatment decision that follows, or both. To arrange one, you will need the PET scan images and the written report — your clinic team can help with this. A second opinion is not a sign of distrust; it is a normal part of making a significant treatment decision, and most oncologists support it.